← Leaderboards
Cenk Ayata
Massachusetts General Hospital
$15,872,648
Attributed
$17,615,718
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,615,718 · 9
By mechanism
R01$8,573,882 · 4
P50$3,833,579 · 1
U01$3,050,370 · 2
P01$2,157,887 · 2
Top collaborators
- Sava Sakadzic5 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mingming Ning$8,518,949
- Elizabeth M. C. Hillman$26,584,494
- Michael A Moskowitz$13,795,692
- Georges El Fakhri$43,967,178
- Giorgio Bonmassar$14,077,156
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesBlood VesselsStrokeCerebrovascular CirculationBrainResponseCerebrumAcuteNeurologicFunctional DisorderPharmaceutical PreparationsCerebral IschemiaChronicIschemic StrokeClinically RelevantInfarctionPublishingGeneticClinical TrialsAcute StrokePreventIschemiaDoseMiddle Cerebral Artery Occlusion
Grant awards (35)
Stroke Preclicinal Assessment Network$577,622
U01 · FY2025 · NS · contact PI
Safety of Anti-CGRP Migraine Therapeutics in Ischemic Stroke$499,509
R01 · FY2025 · NS · contact PI
Investigating the Microvascular Mechanisms of O2 Supply-Demand Mismatch in Small Vessel Disease using Novel High-Resolution Optical Imaging$658,720
R01 · FY2024 · NS
Stroke Preclicinal Assessment Network$622,548
U01 · FY2024 · NS · contact PI
Safety of Anti-CGRP Migraine Therapeutics in Ischemic Stroke$449,941
R01 · FY2024 · NS · contact PI
Investigating the microvascular mechanisms of O2 supply-demand mismatch in small vessel disease using novel high-resolution optical imaging$693,183
R01 · FY2023 · NS
Stroke Preclicinal Assessment Network$661,021
U01 · FY2023 · NS · contact PI
Safety of Anti-CGRP Migraine Therapeutics in Ischemic Stroke$458,347
R01 · FY2023 · NS · contact PI
Investigating the microvascular mechanisms of O2 supply-demand mismatch in small vessel disease using novel high-resolution optical imaging$689,926
R01 · FY2022 · NS
Investigating the microvascular mechanisms of O2 supply-demand mismatch in small vessel disease using novel high-resolution optical imaging$736,716
R01 · FY2021 · NS
Multicenter preclinical trial of rho-kinase inhibitor fasudil in acute focal cerebral ischemia and reperfusion$530,827
U01 · FY2021 · NS · contact PI
Non-invasive vagus nerve stimulation targeting cortical spreading depression in migrane prophylaxis$373,558
R01 · FY2021 · NS · contact PI
Investigating the microvascular mechanisms of O2 supply-demand mismatch in small vessel disease using novel high-resolution optical imaging$707,596
R01 · FY2020 · NS
Multicenter preclinical trial of rho-kinase inhibitor fasudil in acute focal cerebral ischemia and reperfusion$533,259
U01 · FY2020 · NS · contact PI
Non-invasive vagus nerve stimulation targeting cortical spreading depression in migrane prophylaxis$373,454
R01 · FY2020 · NS · contact PI
Non-invasive vagus nerve stimulation targeting cortical spreading depression in migrane prophylaxis$373,247
R01 · FY2019 · NS · contact PI
Multicenter preclinical trial of rho-kinase inhibitor fasudil in acute focal cerebral ischemia and reperfusion$125,093
U01 · FY2019 · NS · contact PI
Non-invasive vagus nerve stimulation targeting cortical spreading depression in migrane prophylaxis$373,131
R01 · FY2018 · NS · contact PI
Non-invasive vagus nerve stimulation targeting cortical spreading depression in migrane prophylaxis$366,509
R01 · FY2017 · NS · contact PI
Targeting ROCK for Neurogliovascular Plasticity & Remodeling After Stroke$295,258
P01 · FY2015 · NS · contact PI
Targeting ROCK for Neurogliovascular Plasticity & Remodeling After Stroke$295,258
P01 · FY2014 · NS · contact PI
Arise$904,954
P50 · FY2013 · NS · contact PI
Arise$539,952
P50 · FY2012 · NS · contact PI
Neural & Vascular Dysfunction As Mechanisms of Injury in Genetic Migraine Models$357,530
R01 · FY2012 · NS · contact PI
Arise$528,451
P50 · FY2011 · NS · contact PI
Neural & Vascular Dysfunction As Mechanisms of Injury in Genetic Migraine Models$357,530
R01 · FY2011 · NS · contact PI
Neurovascular coupling during intense neuroglial depolarizations$324,718
P01 · FY2011 · NS · contact PI
Arise$1,860,222
P50 · FY2010 · NS · contact PI
Neural & Vascular Dysfunction As Mechanisms of Injury in Genetic Migraine Models$361,179
R01 · FY2010 · NS · contact PI
Neurovascular coupling during intense neuroglial depolarizations$324,639
P01 · FY2010 · NS · contact PI
Neural & Vascular Dysfunction As Mechanisms of Injury in Genetic Migraine Models$363,428
R01 · FY2009 · NS · contact PI
Neurovascular coupling during intense neuroglial depolarizations$318,295
P01 · FY2009 · NS · contact PI
Neural & Vascular Dysfunction As Mechanisms of Injury in Genetic Migraine Models$380,378
R01 · FY2008 · NS · contact PI
Neurovascular coupling during intense neuroglial depolarizations$308,946
P01 · FY2008 · NS · contact PI
Neurovascular coupling during intense neuroglial depolarizations$290,773
P01 · FY2007 · NS · contact PI